Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 221 citing articles:

2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Clinical and Molecular Hepatology (2022) Vol. 28, Iss. 4, pp. 583-705
Open Access | Times Cited: 195
2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma

Korean Journal of Radiology (2022) Vol. 23, Iss. 12, pp. 1126-1126
Open Access | Times Cited: 90
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Journal of Liver Cancer (2022) Vol. 23, Iss. 1, pp. 1-120
Open Access | Times Cited: 83
Imaging to Predict Prognosis in Hepatocellular Carcinoma: Current and Future Perspectives
Maxime Ronot, Victoria Chernyak, Adam M. Burgoyne, et al.
Radiology (2023) Vol. 307, Iss. 3
Closed Access | Times Cited: 54
Liver Resection Versus Local Ablation Therapies for Hepatocellular Carcinoma Within the Milan Criteria
Seong Wook Shin, Keun Soo Ahn, Sang Woo Kim, et al.
Annals of Surgery (2020) Vol. 273, Iss. 4, pp. 656-666
Closed Access | Times Cited: 120
Treatment and the prognosis of hepatocellular carcinoma in Asia
Takuji Torimura, Hideki Iwamoto
Liver International (2021) Vol. 42, Iss. 9, pp. 2042-2054
Open Access | Times Cited: 83
Burden of liver cancer: From epidemiology to prevention
Qianru Li, Maomao Cao, Lin Lei, et al.
Chinese Journal of Cancer Research (2022) Vol. 34, Iss. 3, pp. 554-566
Open Access | Times Cited: 65
Case Report: Successful immune checkpoint inhibitor rechallenge after sintilimab-induced Guillain-Barré syndrome
Ye Lin, Wenbo Yue, Hao Shi, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
Radiologic-Pathologic Correlation of Hepatobiliary Phase Hypointense Nodules without Arterial Phase Hyperenhancement at Gadoxetic Acid–enhanced MRI: A Multicenter Study
Ijin Joo, So Yeon Kim, Tae Wook Kang, et al.
Radiology (2020) Vol. 296, Iss. 2, pp. 335-345
Open Access | Times Cited: 56
Outcome of No-Touch Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Multicenter Clinical Trial
Dong Ho Lee, Min Woo Lee, Pyo Nyun Kim, et al.
Radiology (2021) Vol. 301, Iss. 1, pp. 229-236
Closed Access | Times Cited: 55
Laparoscopic Liver Resection versus Percutaneous Radiofrequency Ablation for Small Single Nodular Hepatocellular Carcinoma: Comparison of Treatment Outcomes
Dong Ho Lee, Jing Woong Kim, Jeong Min Lee, et al.
Liver Cancer (2021) Vol. 10, Iss. 1, pp. 25-37
Open Access | Times Cited: 51
Abbreviated magnetic resonance imaging vs ultrasound for surveillance of hepatocellular carcinoma in high‐risk patients
Hyo Jung Park, So Yeon Kim, Amit G. Singal, et al.
Liver International (2021) Vol. 42, Iss. 9, pp. 2080-2092
Closed Access | Times Cited: 43
Diagnosing Hepatocellular Carcinoma Using Sonazoid Contrast-Enhanced Ultrasonography: 2023 Guidelines From the Korean Society of Radiology and the Korean Society of Abdominal Radiology
Woo Kyoung Jeong, Hyo‐Jin Kang, Sang Hyun Choi, et al.
Korean Journal of Radiology (2023) Vol. 24, Iss. 6, pp. 482-482
Open Access | Times Cited: 19
Contrast-enhanced US with Sulfur Hexafluoride and Perfluorobutane: LI-RADS for Diagnosing Hepatocellular Carcinoma
Lingling Li, Xuebin Zou, Wei Zheng, et al.
Radiology (2023) Vol. 308, Iss. 2
Closed Access | Times Cited: 17
Comparison of diagnostic performance of non-contrast MRI and abbreviated MRI using gadoxetic acid in initially diagnosed hepatocellular carcinoma patients: a simulation study of surveillance for hepatocellular carcinomas
Sunyoung Whang, Moon Hyung Choi, Joon‐Il Choi, et al.
European Radiology (2020) Vol. 30, Iss. 8, pp. 4150-4163
Closed Access | Times Cited: 42
Noncontrast MRI for Hepatocellular Carcinoma Detection: A Systematic Review and Meta-analysis – A Potential Surveillance Tool?
Michael Chan, Ya Ruth Huo, Nelson Trieu, et al.
Clinical Gastroenterology and Hepatology (2021) Vol. 20, Iss. 1, pp. 44-56.e2
Open Access | Times Cited: 39
Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Current Progresses and Challenges
Yu‐Xian Teng, Si Xie, Pingping Guo, et al.
Journal of Clinical and Translational Hepatology (2022) Vol. 10, Iss. 5, pp. 955-964
Open Access | Times Cited: 26
Comparison of the outcomes between sorafenib and lenvatinib as the first-line systemic treatment for HBV-associated hepatocellular carcinoma: a propensity score matching analysis
Na Ryung Choi, Ju Yeon Kim, Ji Hoon Hong, et al.
BMC Gastroenterology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 23
Development of a Model including MRI Features for Predicting Advanced-stage Recurrence of Hepatocellular Carcinoma after Liver Resection
Hanyu Jiang, Chongtu Yang, Yidi Chen, et al.
Radiology (2023) Vol. 309, Iss. 2
Closed Access | Times Cited: 15
No-Touch Radiofrequency Ablation for Early Hepatocellular Carcinoma: 2023 Korean Society of Image-Guided Tumor Ablation Guidelines
Seungchul Han, Min Woo Lee, Young Joon Lee, et al.
Korean Journal of Radiology (2023) Vol. 24, Iss. 8, pp. 719-719
Open Access | Times Cited: 14
TACE plus tyrosine kinase inhibitors and immune checkpoint inhibitors versus TACE plus tyrosine kinase inhibitors for the treatment of patients with hepatocellular carcinoma: a meta-analysis and trial sequential analysis
Jiaxi Liu, Peng Wang, Liqi Shang, et al.
Hepatology International (2023) Vol. 18, Iss. 2, pp. 595-609
Closed Access | Times Cited: 14
Irradiation stent with 125I plus TACE versus sorafenib plus TACE for hepatocellular carcinoma with major portal vein tumor thrombosis: a multicenter randomized trial
Jian Lü, Jin-He Guo, Jiansong Ji, et al.
International Journal of Surgery (2023) Vol. 109, Iss. 5, pp. 1188-1198
Open Access | Times Cited: 13
Early Predictors of Objective Response in Patients with Hepatocellular Carcinoma Undergoing Lenvatinib Treatment
Issei Saeki, Takahiro Yamasaki, Satoyoshi Yamashita, et al.
Cancers (2020) Vol. 12, Iss. 4, pp. 779-779
Open Access | Times Cited: 37
The efficacies of entecavir and tenofovir in terms of enhancing prognosis after curative treatment of hepatitis B virus–related hepatocellular carcinoma
Ji Hyun Lee, Beom Kyung Kim, Soo Young Park, et al.
European Journal of Internal Medicine (2021) Vol. 89, pp. 48-55
Closed Access | Times Cited: 29
Contrast-Enhanced Ultrasound Using Perfluorobutane: Impact of Proposed Modified LI-RADS Criteria on Hepatocellular Carcinoma Detection
Lingling Li, Wei Zheng, Jianwei Wang, et al.
American Journal of Roentgenology (2022) Vol. 219, Iss. 3, pp. 434-443
Closed Access | Times Cited: 22
Page 1 - Next Page

Scroll to top